ADDEX THERAPEUTICS LTD (ADXN)
US00654J2069 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.56M | -20.80M | -15.35M | -12.86M | -14.78M | |||
| Depreciation Amortization | 305.95K | 323.14K | 347.61K | 378.75K | 333.84K | |||
| Change In Working Capital | 213.76K | 157.68K | -761.57K | -1.82M | 2.66M | |||
| Interest Paid | 21.61K | 48.90K | 63.01K | 69.50K | 128.52K | |||
| Other non cash items | 2.04M | 3.89M | 1.06M | 2.12M | 2.31M | |||
| OPERATING CASH FLOW | -7.99M | -16.44M | -14.71M | -12.18M | -9.48M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6.84K | -580.00 | -31.55K | -59.41K | -28.46K | |||
| Other Investing Activity | 0.00 | 3.55K | 1.24K | 0.00 | -14.80K | |||
| INVESTING CASH FLOW | -6.84K | 2.97K | -30.31K | -59.41K | -43.25K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -281.79K | -288.08K | -309.62K | -367.41K | -316.79K | |||
| Stock Issued/Repurchased | 4.49M | 3.99M | 19.04M | 720.01K | 5.99K | |||
| Other Financing Activity | 1.06M | -599.25K | -2.33M | -306.20K | -152.89K | |||
| FINANCING CASH FLOW | 5.26M | 3.10M | 16.40M | 46.40K | -463.70K | |||
| Exchange Rate Effect | -356.95K | -196.23K | 122.47K | -648.68K | -144.30K | |||
| CHANGE IN CASH | -3.09M | -13.53M | 1.79M | -12.84M | -10.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.99M | -16.44M | -14.71M | -12.18M | -9.48M | |||
| Capital Expenditure | -6.84K | -580.00 | -31.55K | -59.41K | -28.46K | |||
| FREE CASH FLOW | -8.00M | -16.44M | -14.74M | -12.24M | -9.51M | |||
All data in CHF